Invirsa

0 followers


Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Shalwitz
Founder & CEO

Robert Shalwitz

Collapse
Rachael Wingo
Chief Financial Officer
Isaiah Shalwitz
VP, Business Development & Operations
Cindy Flinn
Senior Director Program Management
Alexandrea M.
Manager of CMC and R&D
Faith V.
Board Director